Q3 FY26: revenue up 13.5% YoY, PAT drops 79% on lower other income
ALPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250 and 4.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Alpa Labs Q3 FY26 standalone revenue grew 13.5% YoY to Rs 29.67 cr from Rs 26.15 cr. Core operating profit improved sharply from near-zero last year. However, PAT fell 79% to Rs 1.87 cr from Rs 8.91 cr as other income plunged to Rs 26 lakh from Rs 8.80 cr. Nine-month revenue rose 2.6% to Rs 74.41 cr while PAT declined 37% to Rs 13.75 cr. Auditor C.H. Padliya gave a clean review report.
Strong operating performance contrasts with sharp PAT drop on lower other income. Core business momentum is positive but headline numbers may weigh on sentiment.